Lv1
20 积分 2021-06-23 加入
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
15小时前
待确认
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
6天前
已完结
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia
12天前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
12天前
已完结
Lipid-regulated phosphorylation hierarchy of the T cell receptor tyrosine motifs
13天前
已完结
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis
13天前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
14天前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
14天前
已完结
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
14天前
已完结
CAR T-cell Therapy in SLE: A Systematic Review
15天前
已完结
皖公网安备34019202002308
